Clinical progress in inherited retinal degenerations: gene therapy clinical trials and advances in genetic sequencing

BP Hafler - Retina, 2017 - journals.lww.com
Purpose: Inherited retinal dystrophies are a significant cause of vision loss and are
characterized by the loss of photoreceptors and the retinal pigment epithelium (RPE) …

CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (LCA10)

ML Maeder, DA Bumcrot, S Shen - US Patent 9,938,521, 2018 - Google Patents
US9938521B2 - CRISPR/CAS-related methods and compositions for treating leber's
congenital amaurosis 10 (LCA10) - Google Patents US9938521B2 - CRISPR/CAS-related …

[HTML][HTML] Focus: Genome editing: Potential of gene editing and induced pluripotent stem cells (iPSCs) in treatment of retinal diseases

K Chuang, MA Fields, LV Del Priore - The Yale journal of biology …, 2017 - ncbi.nlm.nih.gov
The advent of gene editing has introduced the ability to make changes to the genome of
cells, thus allowing for correction of genetic mutations in patients with monogenic diseases …

Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models

A McDonald, J Wijnholds - International Journal of Molecular Sciences, 2024 - mdpi.com
The human photoreceptor function is dependent on a highly specialised cilium. Perturbation
of cilial function can often lead to death of the photoreceptor and loss of vision. Retinal …

CRISPR genome surgery in the retina in light of off-targeting

GY Cho, KA Schaefer, AG Bassuk, SH Tsang… - Retina, 2018 - journals.lww.com
Purpose: Recent concerns regarding the clinical utilization of clustered regularly interspaced
short palindromic repeats (CRISPR) involve uncertainties about the potential detrimental …

CRISPR-mediated ophthalmic genome surgery

GY Cho, Y Abdulla, JD Sengillo, S Justus… - Current ophthalmology …, 2017 - Springer
Abstract Purpose of Review Clustered regularly interspaced short palindromic repeats
(CRISPR) system is a genome engineering system with great potential for clinical …

Genome editing: the breakthrough technology for inherited retinal disease?

AJ Smith, SP Carter, BN Kennedy - Expert Opinion on Biological …, 2017 - Taylor & Francis
Introduction: Genetic alterations resulting in a dysfunctional retinal pigment epithelium
and/or degenerating photoreceptors cause impaired vision. These juxtaposed cells in the …

In vivo versus ex vivo CRISPR therapies for retinal dystrophy

B Bakondi - Expert review of ophthalmology, 2016 - Taylor & Francis
Two therapeutic paths have been proposed to treat inherited retinal dystrophy using
clustered regularly interspaced short palindromic repeats (CRISPR). One strategy is to …

CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)

ML Maeder, DA Bumcrot, S Shen - US Patent 10,253,312, 2019 - Google Patents
KMASKRIRDRONCR-JEDNCBNOSA-N O= C [C@ H]([U]) O [C@@ H](C= O) CO Chemical
compound O= C [C@ H]([U]) O [C@@ H](C= O) CO KMASKRIRDRONCR-JEDNCBNOSA-N …

Utilizing CRISPR/cas9-mediated technology to treat inherited retinal diseases: A systematic review

Y Rautavaara - 2022 - diva-portal.org
Inherited retinal diseases are considered as a leading cause of vision loss in a young
population. Neither a permanent cure nor long-term treatment has yet been discovered …